High cost of cardiopulmonary bypass equipment can hamper the global cardiopulmonary bypass equipment market growth. Cardiopulmonary bypass, also known as heart-lung bypass, is an extracorporeal technique that temporarily takes over the function of the heart and lungs during surgery, thus, maintaining the circulation of blood and the oxygen content of the tissues. This allows the heart to be stopped, and works of repairing or correcting defects to be carried out. The equipment required for cardiopulmonary bypass includes the heart-lung machine, oxygenators, cannulae, blood cardioplegia systems, and cooling and warming devices. This specialized medical equipment is highly complex and incorporates advanced biomedical engineering technologies. Oxygenators use over 100,000 hollow fibers made from biocompatible polymers to effectively oxygenate blood outside the body. Due to stringent requirements for safety, reliability and sterile processing, materials and manufacturing of cardiopulmonary bypass equipment requires heavy investments. Furthermore, the devices need to undergo rigorous testing and clinical validations to obtain regulatory approvals.
Market Opportunities: Growing demand for minimally invasive procedures
Growing demand for minimally invasive surgical procedures can offer market growth opportunities. Patients are increasingly opting for procedures that allow for smaller incisions, reduced pain and scarring, and shorter hospitalization times. This trend towards minimally invasive surgeries can drive the cardiopulmonary bypass equipment market growth. As hospitals and cardiac clinics cater to patient demand and preferences, these are investing more in equipment like miniaturized cardiopulseter pumps, low-volume cardiopulmonary bypass circuits, and portable heart-lung machines that support minimally invasive cardiac procedures. The availability of such advanced yet smaller bypass equipment enables complex cardiac surgeries to be performed through smaller access points rather than traditional open-heart operations. This leads to significantly faster recovery times for patients and reduced risk of surgical site infections. According to a 2021 report by the UN Department of Economic and Social Affairs, the global population aged 65 years and older is projected to double from 727 million to nearly 1.5 billion between 2020 and 2050. This growing geriatric population can increase age-related cardiac conditions that often require surgical treatment.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients